News
HotCopper on MSN33m
Argenica doses final patients in acute ischaemic stroke trialArgenica Therapeutics (ASX:AGN) has achieved another important step in the progression of its Phase 2 trial to assess drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback